XML 30 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Common Stock, Value, Outstanding $ 11.3          
Additional Paid in Capital 0.0          
Retained Earnings (Accumulated Deficit) 3,588.5          
Treasury Stock, Value (951.8)          
Accumulated Other Comprehensive Income (Loss), Net of Tax 69.4          
BALANCE at Dec. 31, 2012 2,717.4          
Net earnings attributable to Laboratory Corporation of America Holdings 573.8 $ 0.0 $ 0.0 $ 573.8 $ 0.0 $ 0.0
Other comprehensive earnings, net of tax (3.2) 0.0 0.0 0.0 0.0 (3.2)
Issuance of common stock under employee stock plans 174.0 0.2 173.8 0.0 0.0 0.0
Surrender of restricted stock and performance share awards (7.1) 0.0 0.0 0.0 (7.1) 0.0
Conversion of zero-coupon convertible debt 4.1 0.0 4.1 0.0 0.0 0.0
Stock compensation 37.3 0.0 37.3 0.0 0.0 0.0
Income tax benefit from stock options exercised 10.6 0.0 10.6 0.0 0.0 0.0
Purchase of common stock (1,015.6) (1.0) (225.8) (788.8) 0.0 0.0
BALANCE at Dec. 31, 2013 2,491.3          
Common Stock, Value, Outstanding   10.5        
Additional Paid in Capital     0.0      
Retained Earnings (Accumulated Deficit)       3,373.5    
Treasury Stock, Value         (958.9)  
Accumulated Other Comprehensive Income (Loss), Net of Tax 66.2         66.2
Net earnings attributable to Laboratory Corporation of America Holdings 511.2 0.0 0.0 511.2 0.0 0.0
Other comprehensive earnings, net of tax (76.7) 0.0 0.0 0.0 0.0 (76.7)
Issuance of common stock under employee stock plans 114.8 0.2 114.6 0.0 0.0 0.0
Surrender of restricted stock and performance share awards (6.6) 0.0 0.0 0.0 (6.6) 0.0
Conversion of zero-coupon convertible debt 3.9 0.0 3.9 0.0 0.0 0.0
Stock compensation 45.7 0.0 45.7 0.0 0.0 0.0
Income tax benefit from stock options exercised 5.9 0.0 5.9 0.0 0.0 0.0
Purchase of common stock (269.0) (0.3) (170.1) (98.6) 0.0 0.0
BALANCE at Dec. 31, 2014 2,820.5          
Common Stock, Value, Outstanding 10.4 10.4        
Additional Paid in Capital 0.0   0.0      
Retained Earnings (Accumulated Deficit) 3,786.1     3,786.1    
Treasury Stock, Value (965.5)       (965.5)  
Accumulated Other Comprehensive Income (Loss), Net of Tax (10.5)         (10.5)
Net earnings attributable to Laboratory Corporation of America Holdings 436.9 0.0 0.0 436.9 0.0 0.0
Other comprehensive earnings, net of tax (276.5) 0.0 0.0 0.0 0.0 (276.5)
Issuance of common stock for acquisition consideration 1,762.5 1.5 1,761.0 0.0 0.0 0.0
Issuance of common stock under employee stock plans 98.9 0.1 98.8 0.0 0.0 0.0
Surrender of restricted stock and performance share awards (12.6) 0.0 0.0 0.0 (12.6) 0.0
Conversion of zero-coupon convertible debt 0.4 0.0 0.4 0.0 0.0 0.0
Stock compensation 102.1 0.0 102.1 0.0 0.0 0.0
Income tax benefit from stock options exercised 12.2 0.0 12.2 0.0 0.0 0.0
BALANCE at Dec. 31, 2015 4,944.4          
Common Stock, Value, Outstanding 12.0 $ 12.0        
Additional Paid in Capital 1,974.5   $ 1,974.5      
Retained Earnings (Accumulated Deficit) 4,223.0     $ 4,223.0    
Treasury Stock, Value (978.1)       $ (978.1)  
Accumulated Other Comprehensive Income (Loss), Net of Tax $ (287.0)         $ (287.0)